{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:05:57Z","timestamp":1791216357556,"version":"4.1.0"},"reference-count":24,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHR"],"published-print":{"date-parts":[[2020,10,16]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The change in the prevalence of hypogonadism with age in men with human\nimmunodeficiency virus (HIV) infection is subject to debate.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To address this issue, we diagnosed hypogonadism based on serum levels of free testosterone\n(fTST) rather than total testosterone which is thought to be an inaccurate indicator. We also\ndetermined the relationship between age and fTST levels and identified risk factors for hypogonadism\nin men with HIV infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>We retrospectively reviewed fTST levels and associated clinical factors in 71 wellcontrolled\nHIV-infected men who were treated at Teikyo University Hospital between April 2015\nand March 2016 and who had data available on serum fTST levels, measured &gt;6 months after starting\nantiretroviral therapy. fTST was measured using radioimmunoassay on blood samples collected\nin the morning. Risk factors for hypogonadism were identified using Welch\u2019s t-test and multiple regression\nanalysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The men had a mean (\u00b1 standard deviation) age of 47.4 \u00b1 13.6 years, and mean (\u00b1 standard\ndeviation) serum fTST level of 13.0 \u00b1 6.1 pg\/mL. Fifteen (21.1%) men had hypogonadism based on\na fTST &lt;8.5 pg\/mL. Serum fTST levels significantly decreased with age (\u22120.216 pg\/mL\/year).\nOlder age and low hemoglobin levels were identified as risk factors for hypogonadism.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The men in the study experienced a more rapid decline in fTST levels with age than\nmen in the general population (\u22120.161 pg\/mL\/year). Serum fTST levels in men with HIV infection\nshould be monitored, especially in older men and those with low hemoglobin levels.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570162x18666200720000344","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T06:21:08Z","timestamp":1595226068000},"page":"381-386","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of and Risk Factors for Low Free Testosterone Levels in Japanese Men with Well-controlled Human Immunodeficiency Virus Infection"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-4243","authenticated-orcid":true,"given":"Yusuke","family":"Yoshino","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8744-8745","authenticated-orcid":true,"given":"Ichiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2350-2922","authenticated-orcid":true,"given":"Takatoshi","family":"Kitazawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0144-284X","authenticated-orcid":true,"given":"Yasuo","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03345525","volume":"28","author":"Schubert M.","year":"2005","unstructured":"Schubert M.; Jockenh\u00f6vel F.; Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects. J Endocrinol Invest 2005,28(3)(Suppl.),23-27","journal-title":"J Endocrinol Invest"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1742-1241.2010.02355.x","volume":"64","author":"Dandona P.","year":"2010","unstructured":"Dandona P.; Rosenberg M.T.; A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract 2010,64,682-696","journal-title":"Int J Clin Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/00126334-199208000-00012","volume":"5","author":"Christeff N.","year":"1992","unstructured":"Christeff N.; Gharakhanian S.; Thobie N.; Rozenbaum W.; Nunez E.A.; Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 1992,5(8),841-846","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00002030-199106000-00013","volume":"5","author":"Raffi F.","year":"1991","unstructured":"Raffi F.; Brisseau J.M.; Planchon B.; R\u00e9mi J.P.; Barrier J.H.; Grolleau J.Y.; Endocrine function in 98 HIV-infected patients: a prospective study. AIDS 1991,5(6),729-733","journal-title":"AIDS"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1086\/314027","volume":"31","author":"Wanke C.A.","year":"2000","unstructured":"Wanke C.A.; Silva M.; Knox T.A.; Forrester J.; Speigelman D.; Gorbach S.L.; Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000,31(3),803-805","journal-title":"Clin Infect Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1210\/jc.2003-031719","volume":"89","author":"Araujo A.B.","year":"2004","unstructured":"Araujo A.B.; O\u2019Donnell A.B.; Brambilla D.J.; Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004,89(12),5920-5926","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-6405-11-6.","volume":"11","author":"Monroe A.K.","year":"2014","unstructured":"Monroe A.K.; Dobs A.S.; Palella F.J.; Kingsley L.A.; Witt M.D.; Brown T.T.; Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism. AIDS Res Ther 2014,11,6","journal-title":"AIDS Res Ther"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028512","volume":"6","author":"Rochira V.","year":"2011","unstructured":"Rochira V.; Zirilli L.; Orlando G.; Santi D.; Brigante G.; Diazzi C.; Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS One 2011,6","journal-title":"PLoS One"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/apc.2006.0071","volume":"21","author":"Crum-Cianflone N.F.","year":"2007","unstructured":"Crum-Cianflone N.F.; Bavaro M.; Hale B.; Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007,21(1),9-19","journal-title":"AIDS Patient Care STDS"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/QAD.0000000000001348","volume":"31","author":"Lach\u00e2tre M.","year":"2017","unstructured":"Lach\u00e2tre M.; Pasquet A.; Ajana F.; Soudan B.; Lion G.; Bocket L.; HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy. AIDS 2017,31,451-453","journal-title":"AIDS"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jiac.2018.09.007.","volume":"25","author":"Yoshino Y.","year":"2019","unstructured":"Yoshino Y.; Koga I.; Misu K.; Seo K.; Kitazawa T.; Ota Y.; The prevalence of low serum free testosterone and the short-term effect of anti-retroviral therapy in male Japanese treatment-naive HIV patients. J Infect Chemother 2019,25,318-321","journal-title":"J Infect Chemother"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1442-2042.2008.02203.x.","volume":"16","author":"Iwamoto T.","year":"2009","unstructured":"Iwamoto T.; Yanase T.; Horie H.; Namiki M.; Okuyama A.; Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan. Int J Urol 2009,16,168-174","journal-title":"Int J Urol"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174360.","volume":"12","author":"Iwamoto A.","year":"2017","unstructured":"Iwamoto A.; Taira R.; Yokomaku Y.; Koibuchi T.; Rahman M.; Izumi Y.; The HIV care cascade: Japanese perspectives. PLoS One 2017,12","journal-title":"PLoS One"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1442-2042.2008.02010.x","volume":"15","author":"Namiki M.","year":"2008","unstructured":"Namiki M.; Akaza H.; Shimazui T.; Ito N.; Iwamoto T.; Baba K.; Clinical practice manual for late-onset hypogonadism syndrome. Int J Urol 2008,15,377-388","journal-title":"Int J Urol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1086\/523577.","volume":"45","author":"Goulet J.L.","year":"2007","unstructured":"Goulet J.L.; Fultz S.L.; Rimland D.; Butt A.; Gibert C.; Rodriguez-Barradas M.; Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007,45,1593-1601","journal-title":"Clin Infect Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627.","volume":"53","author":"Guaraldi G.","year":"2011","unstructured":"Guaraldi G.; Orlando G.; Zona S.; Menozzi M.; Carli F.; Garlassi E.; Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011,53,1120-1126","journal-title":"Clin Infect Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13685538.2016.1229764","volume":"19","author":"Shin Y.S.","year":"2016","unstructured":"Shin Y.S.; You J.H.; Cha J.S.; Park J.K.; The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men. Aging Male 2016,19(4),209-214","journal-title":"Aging Male"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/gerona\/glt154","volume":"69","author":"Bachman E.","year":"2014","unstructured":"Bachman E.; Travison T.G.; Basaria S.; Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point. J Gerontol A Biol Sci Med Sci 2014,69(6),725-735","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1743-6109.2009.01473.x","volume":"7","author":"Moreno S.A.","year":"2010","unstructured":"Moreno S.A.; Shyam A.; Morgentaler A.; Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population. J Sex Med 2010,7,1948-1953","journal-title":"J Sex Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5980\/jpnjurol1989.95.751","volume":"95","author":"Iwamoto T.","year":"2004","unstructured":"Iwamoto T.; Yanase T.; Koh E.; Horie H.; Baba K.; Namiki M.; Reference ranges of total serum and free testosterone in Japanese male adults. Japan J Urol 2004,95,751-760","journal-title":"Japan J Urol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2265.1993.tb01769.x","volume":"39","author":"Cooke R.R.","year":"1993","unstructured":"Cooke R.R.; McIntosh J.E.; McIntosh R.P.; Circadian variation in serum free and non-SHBG-bound testosterone in normal men: measurements, and simulation using a mass action model. Clin Endocrinol (Oxf) 1993,39(2),163-171","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrurol.2011.47","volume":"8","author":"Huhtaniemi I.","year":"2011","unstructured":"Huhtaniemi I.; Forti G.; Male late-onset hypogonadism: pathogenesis, diagnosis and treatment. Nat Rev Urol 2011,8(6),335-344","journal-title":"Nat Rev Urol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/jc.2011-2591","volume":"97","author":"Shores M.M.","year":"2012","unstructured":"Shores M.M.; Smith N.L.; Forsberg C.W.; Anawalt B.D.; Matsumoto A.M.; Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 2012,97(6),2050-2058","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"Grulich A.E.","year":"2007","unstructured":"Grulich A.E.; van Leeuwen M.T.; Falster M.O.; Vajdic C.M.; Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007,370(9581),59-67","journal-title":"Lancet"}],"container-title":["Current HIV Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183918","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183918\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T15:43:56Z","timestamp":1615391036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183918\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570162x18666200720000344","relation":{},"ISSN":["1570-162X"],"issn-type":[{"value":"1570-162X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}